Evercore ISI Upgrades Augmedix (NASDAQ:AUGX) to Outperform : vimarsana.com

Augmedix (NASDAQ:AUGX – Get Free Report) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a report issued on Tuesday, Benzinga reports. The firm presently has a $5.00 price objective on the stock, up from their previous price objective of $4.50. Evercore ISI’s target price indicates a potential […]

Related Keywords

United States , Ian Shakil , Augmedix Company Profile , Securities Exchange Commission , Verition Fund Management , Symmetry Peak Management , Maxim Group , Nasdaq , Acadian Asset Management , Augmedix Inc , Worth Venture Partners , Thompson Davis , Get Free Report , Exchange Commission , Asset Management , Peak Management , Venture Partners , Augmedix Live , Augmedix Go Assist , Augmedix Prep , Augmedix Daily , Augmedix , Nasdaq Augx , Augx , Medical , Upgrade , Evercore Isi ,